Revenues increased in the first quarter by 17.5 percent to 72.4 (61.6) after strong growth from both business units. "I am satisfied to see such strong growth compared to previous year given that the first quarter last year was a record quarter", comments Torbjörn Sköld.
The gross profit amounted to 42.4 percent (44.8). Business unit Surgical Tables was affected by an unfavorable product and market mix, while Surgical Instruments was positively affected by the same factors. Operating profit, before one-time costs, amounted to 10.4 MSEK (7.6).
"Stille's strategic and financial goals remain. With our high-quality products within surgical instruments and radiolucent surgical tables, we will operate in niche premium segments. 2023 has started well for Stille. We continue to deliver value to our customers, which creates good demand, strong growth and good cashflow", concludes Stille's CEO.
MSEK | JAN-MAR 2023 | JAN-MAR 2022 | APR-MAR 2022/2023 | JAN-DEC 2022 |
Revenue | 72.4 | 61.6 | 257.1 | 246.3 |
Gross Profit Margin, % | 42.4 | 44.8 | 42.9 | 45.3 |
EBITDA, before one-time costs | 13.7 | 9.9 | 46.0 | 42.1 |
EBITDA | 10.4 | 9.8 | 42.7 | 42.1 |
Operating Profit, before one-time costs | 10.4 | 7.6 | 35.3 | 32.5 |
Operating Profit | 7.1 | 7.5 | 32.0 | 32.4 |
Operating Profit, % | 9.8 | 12.2 | 10.8 | 13.2 |
Torshälla,
This information is such information that
For more information, please contact:
Torbjörn Sköld
CEO and President
+46 (0)70 316 63 91 | torbjorn.skold@stille.se
https://news.cision.com/stille/r/stille-ab--interim-report-q1-2023,c3759115
https://mb.cision.com/Main/1000/3759115/2015336.pdf
https://mb.cision.com/Public/1000/3759115/8345e9715a7fbc6a.pdf
(c) 2023 Cision. All rights reserved., source